收藏切换
Research progress on traditional Chinese medicine in treatment of inflammatory bowel disease based on gut microbiota-bile acid axis
收藏切换
XIE Yixuan, WEI Xuemei, YANG Yang, LI Yun, WU Jiazhen, LIU Xin, HUANG Yongtong, SU Linqi, ZHANG Yu, GUO Dean, CHEN Qinhua
Chinese Traditional and Herbal Drugs | 2025, 56(22) : 8403 - 8413
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(22): 8403-8413
Research progress on traditional Chinese medicine in treatment of inflammatory bowel disease based on gut microbiota-bile acid axis
Full
XIE Yixuan, WEI Xuemei, YANG Yang, LI Yun, WU Jiazhen, LIU Xin, HUANG Yongtong, SU Linqi, ZHANG Yu, GUO Dean, CHEN Qinhua
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.22.029
Outline
收藏切换
Imbalance of the intestinal microbiota is one of the key factors in the onset and progression of inflammatory bowel disease (IBD). The dysbiosis of intestinal microbiota accelerates the pathological process of IBD by disrupting the homeostasis of bile acids metabolism, exacerbating intestinal inflammatory responses and weakening the intestinal mucosal barrier function. As important microbial-host co-metabolites, abnormally metabolized bile acids, such as the accumulated secondary bile acids and elevated production of toxic metabolites, can activate pro-inflammatory signaling pathways. Furthermore, imbalance of bile acid receptor-mediated regulatory networks amplifies the inflammatory cascade reaction and diminishes the protective functions of intestinal immunity and barrier function, thereby forming a vicious cycle of “microbiota-metabolism-immunity”. With its multi-component, multi-target, and multi-pathway synergistic regulatory features, traditional Chinese medicine (TCM) demonstrates unique advantages in the treatment of IBD. It reshapes the structure of the intestinal microbiota, regulates bile acids metabolism, and restores intestinal immune homeostasis. These mechanisms provide new targets for precise intervention in IBD and establish a theoretical foundation for integrated TCM-Western medicine treatment strategies that combine intestinal microecology and metabolic regulation. Based on this, this review systematically explains the core role of the intestinal microbiota-bile acids axis in the pathogenesis of IBD and summarizes the research progress of TCM in multi-dimensional intervention targeting this axis, aiming to open new avenues for the prevention and treatment of IBD.
intestinal microbiota  /  bile acids  /  traditional Chinese medicine  /  inflammatory bowel disease  /  chenodeoxycholic acid
谢译萱, 魏雪梅, 杨洋, 李运, 吴嘉振, 刘馨, 黄泳彤, 苏琳祺, 张瑜, 果德安, 陈琴华. 基于肠道菌群-胆汁酸轴探讨中药治疗炎症性肠病的研究进展. 中草药, 2025 , 56 (22) : 8403 -8413 . DOI: 10.7501/j.issn.0253-2670.2025.22.029
XIE Yixuan, WEI Xuemei, YANG Yang, LI Yun, WU Jiazhen, LIU Xin, HUANG Yongtong, SU Linqi, ZHANG Yu, GUO Dean, CHEN Qinhua. Research progress on traditional Chinese medicine in treatment of inflammatory bowel disease based on gut microbiota-bile acid axis[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (22) : 8403 -8413 . DOI: 10.7501/j.issn.0253-2670.2025.22.029
Year 2025 volume 56 Issue 22
65
15
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.22.029
  • Receive Date:2025-07-11
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2025-07-11
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.22.029
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT